Identification of myotubularin as the lipid phosphatase catalytic subunit associated with the 3-phosphatase adapter protein, 3-PAP
0301 basic medicine
Recombinant Fusion Proteins
Cell Membrane
Molecular Sequence Data
Proteins
In Vitro Techniques
Protein Tyrosine Phosphatases, Non-Receptor
Phosphoric Monoester Hydrolases
Protein Subunits
03 medical and health sciences
Phenotype
COS Cells
Mutation
Animals
Humans
Amino Acid Sequence
Protein Tyrosine Phosphatases
K562 Cells
Myopathies, Structural, Congenital
DOI:
10.1073/pnas.1033097100
Publication Date:
2003-07-22T19:39:06Z
AUTHORS (9)
ABSTRACT
Myotubularin is a dual-specific phosphatase that dephosphorylates
phosphatidylinositol 3-phosphate and phosphatidylinositol (3,5)-bisphosphate.
Mutations in myotubularin result in the human disease X-linked myotubular
myopathy, characterized by persistence of muscle fibers that retain an
immature phenotype. We have previously reported the identification of the
3-phosphatase adapter protein (3-PAP), a catalytically inactive member of the
myotubularin gene family, which coprecipitates lipid phosphatidylinositol
3-phosphate-3-phosphatase activity from lysates of human platelets. We have
now identified myotubularin as the catalytically active 3-phosphatase subunit
interacting with 3-PAP. A 65-kDa polypeptide, coprecipitating with endogenous
3-PAP, was purified from SDS/PAGE, subjected to trypsin digestion, and
analyzed by collision-induced dissociation tandem MS. Three peptides derived
from human myotubularin were identified. Association between 3-PAP and
myotubularin was confirmed by reciprocal coimmunoprecipitation of both
endogenous and recombinant proteins expressed in K562 cells. Recombinant
myotubularin localized to the plasma membrane, causing extensive filopodia
formation. However, coexpression of 3-PAP with myotubularin led to attenuation
of the plasma membrane phenotype, associated with myotubularin relocalization
to the cytosol. Collectively these studies indicate 3-PAP functions as an
“adapter” for myotubularin, regulating myotubularin intracellular
location and thereby altering the phenotype resulting from myotubularin
overexpression.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (32)
CITATIONS (83)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....